Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Be0ce108be8a237f2c53e2b848d4479a2> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Be0ce108be8a237f2c53e2b848d4479a2 NCIT_P378 "NCI" @default.
- Be0ce108be8a237f2c53e2b848d4479a2 type Axiom @default.
- Be0ce108be8a237f2c53e2b848d4479a2 annotatedProperty IAO_0000115 @default.
- Be0ce108be8a237f2c53e2b848d4479a2 annotatedSource NCIT_C181809 @default.
- Be0ce108be8a237f2c53e2b848d4479a2 annotatedTarget "A regimen consisting of carboplatin, gemcitabine and pembrolizumab that can be used for the treatment of recurrent and metastatic hormone receptor-negative, HER-2 (EGFR2; ErbB2)-negative and PD-L1-positive breast cancer." @default.